Qian-Qian chen | Pharmacology | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Qian-Qian chen | Pharmacology | Best Researcher Award 

Prof. Qian-Qian chen, Nanjing University of Chinese Medicine, China

Prof. Qian-Qian Chen is an Associate Professor at the School of Pharmacy at Nanjing University of Chinese Medicine, China. He holds a Ph.D. in Pharmacognosy from China Pharmaceutical University, Nanjing. His research focuses on the molecular mechanisms of cardiovascular and renal diseases, the regulatory effects of traditional Chinese medicine (TCM) on disease progression, and the role of the neuraminidase protein family in chronic conditions. Prof. Chen has published extensively in high-impact journals such as Advanced Science, Nature Communications, and European Heart Journal. He is committed to advancing both modern pharmacology and TCM in the context of chronic diseases.

Author Profile

Orcid Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Qian-Qian Chen began his academic journey with a Bachelor of Science in Pharmacy from Beihua University, Jilin, China, graduating in June 2015. Demonstrating exceptional academic potential, he pursued a Master’s degree in Pharmacy at China Pharmaceutical University, Nanjing, China, from September 2015 to July 2018. He further refined his expertise by completing a Ph.D. in Pharmacognosy at the same university, achieving his doctorate in July 2021.

🏫PROFESSIONAL ENDEAVORS:

Currently serving as an Associate Professor and Master’s Supervisor in Pharmacology at the School of Pharmacy, Nanjing University of Chinese Medicine, Prof. Chen has been in this role since March 2022. His teaching and mentorship significantly contribute to nurturing the next generation of researchers in pharmacology and traditional Chinese medicine (TCM).

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON Pharmacology:

Prof. Chen’s research is primarily centered around the molecular mechanisms underlying cardiovascular and renal diseases. His work focuses on three major areas:
1️⃣ Exploring the molecular pathways involved in cardiovascular and renal disease progression.
2️⃣ Investigating the regulatory effects of traditional Chinese medicine (TCM) on these diseases.
3️⃣ Unveiling the roles and mechanisms of the neuraminidase protein family in chronic conditions, including ventricular remodeling and chronic kidney injury.

His dedication to these fields has yielded a wealth of insights that advance understanding and treatment strategies for complex cardiorenal syndromes.

📈IMPACT AND INFLUENCE:

Prof. Chen has made significant contributions to the scientific community through his publications in prestigious journals. These include:

  • Advanced Science (2024)
  • Nature Communications (2023)
  • European Heart Journal (2021)
  • Journal of Ethnopharmacology (2021)
  • The American Journal of Chinese Medicine (2021)
  • Circulation (2018)

His groundbreaking studies on cardiovascular and renal diseases have been highly cited and praised for their clinical relevance and innovative methodologies.

📚ACADEMIC CITES AND LEGACY: 

Prof. Chen’s published work has been widely referenced in the fields of pharmacology, traditional Chinese medicine, and chronic disease research. His studies, particularly those addressing the interplay between cardiovascular and renal systems, serve as a cornerstone for researchers exploring related domains.

🌟FUTURE CONTRIBUTIONS AND VISION:

Looking ahead, Prof. Chen aims to:

  • Expand the understanding of traditional Chinese medicine’s regulatory roles in disease mechanisms.
  • Advance therapeutic strategies for chronic diseases through interdisciplinary research.
  • Mentor emerging researchers, fostering innovation and excellence in pharmacological sciences.

His commitment to merging modern scientific techniques with traditional medicine holds the promise of revolutionary breakthroughs in healthcare.

🌍CONCLUSION:

Prof. Qian-Qian Chen’s impressive academic trajectory, impactful research, and dedication to advancing pharmacology place him as a leading figure in his field. His work not only bridges the gap between traditional and modern medicine but also sets a foundation for transformative discoveries that will benefit patients worldwide.

Top Notable Publications:

Targeting Neuraminidase 4 Attenuates Kidney Fibrosis in Mice

Authors: Qian-Qian Chen

Journal: Advanced Science

Year: 2024

DOI: 10.1002/advs.202406936

Neuraminidase 1 is a Driver of Experimental Cardiac Hypertrophy

Authors: Qian-Qian Chen

Journal: European Heart Journal

Year: 2021

DOI: 10.1093/eurheartj/ehab347

Neuraminidase 1 and its Inhibitors from Chinese Herbal Medicines: An Emerging Role for Cardiovascular Diseases

Authors: Qian-Qian Chen

Journal: The American Journal of Chinese Medicine

Year: 2021

DOI: 10.1142/s0192415x21500403

PMID: 33827385

Untargeted Metabolomics and Lipidomics Uncovering the Cardioprotective Effects of Huanglian Jiedu Decoction on Pathological Cardiac Hypertrophy and Remodeling

Authors: Qian-Qian Chen

Journal: Journal of Ethnopharmacology

Year: 2020

DOI: 10.1016/j.jep.2020.113646

PMID: 33264659

Functional Metabolomics Characterizes a Key Role for N-Acetylneuraminic Acid in Coronary Artery Diseases

Authors: Qian-Qian Chen

Journal: Circulation

Year: 2017

DOI: 10.1161/circulationaha.117.031139

PMID: 29212895

Mincai li | vascular calcification | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Dr. Mincai li | vascular calcification | Best Researcher Award 

Prof. Dr. Mincai li, Hubei University of Science and Technology, China

Prof. Dr. Mincai Li is a distinguished academic at Hubei University of Science and Technology, China. He holds an MD and Master’s degree in Pathology and Pathophysiology from Huazhong University of Science and Technology. With extensive experience in teaching, Prof. Li has served as a Professor since 2017, after roles as Associate Professor and Lecturer at the same institution. His research focuses on the molecular mechanisms of atherosclerosis and the efficacy of glioma drugs. He has published over 40 scientific papers, including 15 SCI-indexed articles, and has received multiple awards for his scientific and teaching contributions.

Author Profile

Scopus Profile

🎓 Education Background:

Prof. Dr. Mincai Li completed his MD in Pathology and Pathophysiology at Huazhong University of Science and Technology (2007-2010), graduating in the top 10% of his class. He also earned his Master’s in Pathology and Pathophysiology from the same institution (2004-2007), ranking in the top 10%. Prior to that, he obtained a Bachelor’s in Clinical Medicine from Hubei University of Science and Technology (1993-1998), where he was in the top 30% of his cohort.

💼 Professional Experience:

Prof. Dr. Mincai Li has an extensive academic career at Hubei University of Science and Technology, where he has held progressively senior roles. Since January 2017, he has served as a Professor, following his tenure as Associate Professor from January 2012 to December 2016. From July 2010 to December 2011, he was a Lecturer, and earlier in his career, he worked as a Teaching Assistant from July 1998 to August 2004. Throughout his tenure, Prof. Dr. Li has contributed significantly to education and research in his field, shaping the academic environment at the university.

🩺 Medical Education & Teaching:

Prof. Dr. Mincai Li has made significant contributions to medical education, primarily teaching Pathology and Oral Histopathology courses. He has played a leading role in three provincial teaching research projects within Hubei’s higher education institutions, demonstrating his commitment to advancing academic standards. His exceptional teaching efforts have been recognized with awards, including a second prize and a third prize for teaching achievements at Hubei University of Science and Technology. Prof. Dr. Li’s dedication to both education and research has made a lasting impact on the academic community and the development of future medical professionals.

🔬 Scientific Research:

Prof. Dr. Mincai Li’s research primarily focuses on the molecular mechanisms of atherosclerosis and the efficacy of glioma drugs. He has led and contributed to 10 national, provincial, and municipal research projects, showcasing his expertise in these critical areas. Prof. Li has published over 40 scientific papers, including 15 SCI-indexed articles, and has edited a textbook. His significant contributions to scientific research have earned him recognition, including a second prize and a third prize for scientific and technological progress in Xianning City. His work continues to advance the understanding of critical medical conditions and therapeutic approaches.

🏅 Achievements and Honors:

Prof. Dr. Mincai Li has earned several prestigious awards throughout his career. In 2015, he was honored with the Second and Third Prizes for Science and Technology Progress in Xianning City, recognizing his contributions to scientific advancement. In 2016, he received both the Second and Third Prizes for Teaching Achievements at Hubei Institute of Science and Technology, highlighting his dedication to education. That same year, Prof. Li was awarded the Third Prize for the Second Natural Science Outstanding Academic Achievement Thesis Award in Xianning City, further acknowledging his impactful research and academic excellence. These accolades reflect his commitment to both teaching and scientific progress.

🌟Conclusion:

Prof. Dr. Mincai Li is a highly accomplished academic and researcher at Hubei University of Science and Technology, China. With a strong background in Pathology and Pathophysiology, he has made significant contributions to both education and scientific research. His work on atherosclerosis and glioma drugs has earned him national and regional recognition. As a dedicated professor, he has shaped the academic development of many students, while his research continues to advance medical science. Prof. Li’s numerous awards and honors reflect his unwavering commitment to excellence in both teaching and research.

Top Notable Publications:

Target analysis and identification of curcumin against vascular calcification

Authors: Li, Q., Zhou, Q., Li, S., Li, M., Xia, H.

Journal: Scientific Reports

Year: 2024

The causal relationship between thoracic aortic aneurysm and immune cells: a mendelian randomization study

Authors: Liu, G., Pan, S., Xia, H., Li, M., Wu, A.

Journal: BMC Cardiovascular Disorders

Year: 2024

Attenuating Atherosclerosis through Inhibition of the NF-κB/NLRP3/IL-1β Pathway-Mediated Pyroptosis in Vascular Smooth Muscle Cells (VSMCs)

Authors: Li, S., Li, Q., Zhou, Q., Liu, C., Li, M.

Journal: Cardiovascular Therapeutics

Year: 2024

Identification of key genes and pathways in atherosclerosis using integrated bioinformatics analysis

Authors: Li, S., Li, Q., Zhou, Q., Liu, C., Li, M.

Journal: BMC Medical Genomics

Year: 2023

Bioinformatic Identification of the Pyroptosis-Related Transcription Factor-MicroRNA-Target Gene Regulatory Network in Angiotensin II-Induced Cardiac Remodeling and Validation of Key Components

Authors: Huang, T., Ding, J., Lin, L., Yu, L., Li, M.

Journal: Frontiers in Bioscience (Landmark edition)

Year: 2023

Increased Neuromedin B is Associated with a Favorable Prognosis in Glioblastoma

Authors: Li, S., Li, Q., Zhou, Q., Liu, C., Li, M.

Journal: Frontiers in Bioscience – Landmark

Year: 2023

Study on mechanism of resveratrol regulation of NLRP3 mediated pyroptosis of vascular smooth muscle cells resistance to atherosclerosis

Authors: Li, S., Li, Q., Zhou, C., Ouyang, C., Li, M.

Journal: Drug Evaluation Research

Year: 2022

Curcumin suppresses glioblastoma cell proliferation by p-AKT/mTOR pathway and increases the PTEN expression

Authors: Wang, Z., Liu, F., Liao, W., Li, M., Xia, H.

Journal: Archives of Biochemistry and Biophysics

Year: 2020

Captopril Attenuates the Upregulated Connexin 43 Expression in Artery Calcification

Authors: Li, M., Wang, Z., Shao, J., Yu, L., Hu, Z.

Journal: Archives of Medical Research

Year: 2020

Yan Li | Nutrition | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Dr. Yan Li | Nutrition | Best Researcher Award

Prof. Dr. Yan Li, Jiangnan University, China

Yan Li is a Research Associate at the State Key Laboratory of Food Science and Technology, Jiangnan University, China. He earned his B.Sc. in Food Sciences and Engineering from Jiangnan University in 2012 and a Ph.D. in Biochemistry and Molecular Biology from the Institute for Nutritional Sciences, SIBS, CAS, in 2017. His research focuses on epigenetic regulation of glucose and lipid metabolism, therapeutic strategies for metabolic diseases like T2DM and obesity, and developing functional foods. Yan Li has received multiple honors, including the Young Elite Scientists Sponsorship Program by CAST (2021-2023), showcasing his contributions to advancing health and nutrition science.

Author Profile

Scopus Profile

Orcid Profile

Education Background:

Yan Li completed his education with a strong focus on food sciences and molecular biology. He earned his B.Sc. in Food Sciences and Engineering from Jiangnan University, China, in 2012, where he laid the foundation for his expertise in food technology. He then pursued a Ph.D. in Biochemistry and Molecular Biology at the Institute for Nutritional Sciences, SIBS, CAS, in Shanghai, completing it in 2017 under the supervision of Dr. Hao Ying. His doctoral research focused on cutting-edge areas of molecular biology, particularly epigenetic regulation and metabolic diseases, establishing a solid academic background for his research in health and nutrition.

Professional Experience:

Yan Li has been a Research Associate at the State Key Laboratory of Food Science and Technology, Jiangnan University, since 2017. In this role, he has conducted groundbreaking research on metabolic regulation, focusing on epigenetic mechanisms like microRNAs, acetylation, and lactylation, and their roles in glucose and lipid metabolism. His work extends to developing therapeutic strategies for metabolic disorders such as Type 2 Diabetes Mellitus (T2DM), obesity, and aging-related conditions. Additionally, he explores the functional properties of plant-based ingredients to innovate health and functional foods. Yan Li’s professional experience reflects his dedication to advancing both scientific understanding and practical applications in metabolic health.

Research Interest:

Yan Li‘s research interests focus on the role of epigenetic regulation in metabolic processes, particularly how microRNAs, acetylation, and lactylation influence glucose and lipid metabolism, as well as energy homeostasis. He aims to uncover novel therapeutic strategies for metabolic diseases, including Type 2 Diabetes Mellitus (T2DM), Non-Alcoholic Fatty Liver Disease (NAFLD), aging, and obesity. Additionally, his work explores the mechanisms behind metabolism, exercise, muscle atrophy, and dystrophy, with an emphasis on skeletal muscle regulation. He is also dedicated to investigating the metabolic effects of functional ingredients in cereals and plants, seeking to develop innovative functional foods and health products.

Award and Honors:

Yan Li has received numerous prestigious awards and honors throughout his academic and professional career. These include multiple Outstanding Student Awards from the Chinese Academy of Sciences (2013-2015) and Jiangnan University (2010-2011). He was also recognized as an Outstanding Student Leader by the Chinese Academy of Sciences (2013-2014). In 2014-2015, he received the New World Scholarship from the same institution. Yan Li was awarded the Yihaikerry Teacher Award (2019-2020) and is a recipient of the Young Elite Scientists Sponsorship Program by CAST (2021-2023), highlighting his significant contributions to the field of food science and health research.

Conclusion:

Yan Li is a highly accomplished researcher whose work significantly contributes to the fields of food science, biochemistry, and molecular biology. His research on epigenetic regulation in metabolic diseases, such as Type 2 Diabetes Mellitus, obesity, and aging, alongside his innovative studies on functional foods, positions him as a leading expert in the field. With a solid educational background, extensive research experience, and a history of receiving prestigious awards, Yan Li’s dedication to advancing scientific knowledge and practical health applications makes him a deserving candidate for recognition. His work has the potential to improve global health and nutrition, marking him as an influential researcher.

Top Notable Publications

“Unveiling the potential of germinated black bean extracts: Targeting topoisomerase IIα through in silico and in vitro approaches”

Journal: Food Chemistry

Year: 2025 📅

Citations: 0 📚

“Unveiling the microbiota-mediated impact of different dietary proteins on post-digestive processes: A simulated in vitro approach”

Journal: Food Research International

Year: 2024 📅

Citations: 0 📚

“Unveiling the structural and physico-chemical properties of glutenin macropolymer under frozen storage: Studies on experiments and molecular dynamics simulation”

Journal: Food Research International

Year: 2024 📅

Citations: 0 📚

“Sirtuin 3 reinforces acylcarnitine metabolism and maintains thermogenesis in brown adipose tissue of aging mice”

Journal: Aging Cell

Year: 2024 📅

Citations: 0 📚

“Modifications and in vitro absorption of 5-heptadecyresorcinol from cereals using digestion and ussing chamber models”

Journal: Food Research International

Year: 2024 📅

Citations: 0 📚

“Aqueous Extract of Wolfberry Alleviates Aging-Related Skeletal Muscle Dysfunction by Modulating PRRs Signaling Pathways and Enhancing DNA Repair”

Journal: Molecular Nutrition and Food Research

Year: 2024 📅

Citations: 0 📚

“Research progress of emulsifiers for baking”

Journal: Food and Fermentation Industries

Year: 2024 📅

Citations: 0 📚

“Maternal brown rice diet alleviates adverse effects of maternal obesity on offspring metabolism via enhancing DNA demethylation of AdipoR2”

Journal: Food Bioscience

Year: 2024 📅

Citations: 0 📚

“Maternal Dietary Carbohydrate and Pregnancy Outcomes: Quality over Quantity”

Journal: Nutrients

Year: 2024 📅

Citations: 0 📚

“Quinoa Polyphenol Extract Alleviates Non-Alcoholic Fatty Liver Disease via Inhibiting Lipid Accumulation, Inflammation, and Oxidative Stress”

Journal: Nutrients

Year: 2024 📅

Citations: 1 📚

 

Pingping Yang | Metabolism| Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Pingping Yang | Metabolism| Best Researcher Award

Dr. Pingping Yang,The Second Affiliated Hospital ,Jiangxi Medical College, Nanchang University, Nanchang, China

Dr. Pingping Yang, MD, is an accomplished researcher at Nanchang University, specializing in cardiovascular and nephrology medicine. She earned her Bachelor’s, Master’s, and PhD degrees from Nanchang University, demonstrating academic excellence and dedication to her field. Over the past three years, Dr. Yang has published 16 SCI-indexed papers in renowned journals such as JAMA, Circulation, and Metabolism. Her expertise includes statistical analysis, meta-analysis, and network meta-analysis. Dr. Yang has received numerous accolades, including the National Scholarship and the First Prize for Excellent Paper. Her research contributions significantly impact cardiovascular and kidney disease studies, advancing scientific understanding globally.

🌟Author Profile

Scopus Profile

🎓Education 

Dr. Pingping Yang has an extensive educational background in clinical medicine and specialized fields. She earned her Bachelor’s degree in Clinical Medicine from Nanchang University (2010-2015), laying a strong foundation in medical sciences. Following this, she pursued a Master’s degree in Nephrology at Nanchang University (2015-2018), where she developed specialized knowledge in kidney-related diseases. Demonstrating her commitment to advancing her expertise, Dr. Yang completed her PhD in Cardiovascular Medicine at Nanchang University (2018-2021), focusing on advanced cardiovascular research. Her academic journey reflects her dedication to medical science and her drive to contribute to critical areas of healthcare and research.

💼Professional Experiences 

Dr. Pingping Yang has extensive professional experience in clinical medicine and research. From 2014 to 2015, she practiced at the Second Affiliated Hospital of Nanchang University, gaining hands-on clinical expertise. Between 2015 and 2018, she completed standardized residency training at the same institution, further honing her medical and diagnostic skills. As a dedicated researcher, Dr. Yang has published 16 SCI-indexed papers in prestigious journals, reflecting her expertise in cardiovascular and nephrology medicine. Her proficiency in statistical analysis, including meta-analysis and network meta-analysis, has strengthened her research outcomes, making significant contributions to advancing clinical and translational medical research.

🌍Research Skills 

Dr. Pingping Yang possesses advanced research skills in cardiovascular and nephrology medicine, supported by her extensive academic and professional experience. She excels in statistical analysis, including meta-analysis, network meta-analysis, and proficiency with SPSS software, enabling her to produce high-quality, data-driven research. Dr. Yang’s expertise includes conducting comprehensive literature reviews, designing and analyzing clinical studies, and interpreting complex data sets. Her ability to collaborate on multidisciplinary research has resulted in 16 SCI-indexed publications in top-tier journals like JAMA and Circulation. Dr. Yang’s strong analytical abilities and methodological precision significantly contribute to advancing research in cardiovascular and kidney diseases.

 🏅Awards And Honors 

Dr. Pingping Yang has received numerous awards and honors in recognition of her outstanding academic achievements and research contributions. She was awarded the National Scholarship in 2016 and 2017 for her exceptional performance. Additionally, she received the Special Grade Master’s Scholarship for three consecutive years (2015-2017), highlighting her dedication to academic excellence. Dr. Yang’s research has been widely acknowledged, earning her the Excellent Poster Award at the CSN2016 Academic Conference and the First Prize for Excellent Paper at the 2017 Annual Conference of the Nephrology Branch of Jiangxi Medical Association. These accolades underscore her remarkable contributions to science.

Conclusion 

Dr. Pingping Yang’s exemplary academic achievements and research contributions make her a distinguished candidate for recognition. With 16 SCI-indexed publications in renowned journals such as JAMA, Circulation, and Metabolism, she has demonstrated a profound impact in cardiovascular and nephrology medicine. Her expertise in advanced statistical analysis, including meta-analysis and network meta-analysis, highlights her ability to produce data-driven, high-quality research. Recognized with prestigious awards like the National Scholarship and Excellent Paper Prize, Dr. Yang’s work reflects innovation, dedication, and scholarly excellence. Her contributions not only advance scientific understanding but also set a benchmark for future research in her field.

  📖Publication Top Notes

  • 🧪 PD-1 agonist: A novel therapeutic approach to resolve atherosclerosis
    • Chen, J., Yu, W., Liao, L., Fu, L., Yang, P.
    • Results in Chemistry (2024)
    • 📆 Year: 2024 | 🔖 Citations: 0
  • 🔬 The role of NLRP3 inflammasome in aging and age-related diseases
    • Liang, R., Qi, X., Cai, Q., Zhang, J., Yu, P.
    • Immunity and Ageing (2024)
    • 📆 Year: 2024 | 🔖 Citations: 9
  • 📊 Investigating the research trajectory and future trends of immune disorders in diabetes cardiovascular complications
    • Li, X., Xu, Z., Huang, T., Zhang, J., Yu, P.
    • Ageing Research Reviews (2024)
    • 📆 Year: 2024 | 🔖 Citations: 0
  • 📱 The status quo of short video as sources of health information on gastroesophageal reflux disease in China
    • Cai, Y., Zeng, H., Yang, P., Lai, Y., Zhou, Y.
    • Frontiers in Public Health (2024)
    • 📆 Year: 2024 | 🔖 Citations: 0
  • 💊 Effect of PCSK9 Monoclonal Antibody Versus Placebo/Ezetimibe on Atrial Fibrillation
    • Yang, S., Shen, W., Zhang, H.-Z., Yang, P.-P., Wu, Q.-H.
    • Cardiovascular Drugs and Therapy (2023)
    • 📆 Year: 2023 | 🔖 Citations: 4
  • 🥗 Food-derived peptides as novel therapeutic strategies for NLRP3 inflammasome-related diseases
    • Zhang, Z., Zhang, Y., Zhang, M., Yu, P., Zhang, D.
    • Critical Reviews in Food Science and Nutrition (2023)
    • 📆 Year: 2023 | 🔖 Citations: 2
  • 🦠 Role of NLRP3 inflammasome in diabetes and COVID-19
    • Zhang, J., Ma, X., Liu, F., Liu, J., Yu, P.
    • Frontiers in Immunology (2023)
    • 📆 Year: 2023 | 🔖 Citations: 4
  • ❤️ Finerenone in treatment of cardiovascular and related diseases
    • Yu, W., Shen, W., Yang, P., Wu, T., Wu, Q.
    • Journal of Clinical Cardiology (2022)
    • 📆 Year: 2022 | 🔖 Citations: 2
  • 🔥 Advances in T Cells Based on Inflammation in Metabolic Diseases
    • Yu, W., Li, C., Zhang, D., Zhang, M., Yu, P.
    • Cells (2022)
    • 📆 Year: 2022 | 🔖 Citations: 13
  • 💉 Efficacy and safety of sacubitril/valsartan on heart failure with preserved ejection fraction
    • Yu, W., Zhang, H., Shen, W., Yang, P., Wu, Q.
    • Frontiers in Cardiovascular Medicine (2022)
    • 📆 Year: 2022 | 🔖 Citations: 3

Christopher Coe | Cardiovascular Researches | Best Research Article Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Christopher Coe | Cardiovascular Researches | Best Research Article Award

Prof. Christopher Coe, University of Wisconsin-Madison, United States

Prof. Christopher Coe is a distinguished professor emeritus in psychology at the University of Wisconsin-Madison, recognized for his pioneering work in psychoneuroimmunology and developmental psychobiology. With a career spanning leading institutions, he has made significant contributions to understanding the interaction of stress, immune function, and social behavior, earning numerous accolades for his research and teaching.

Author Profile:

Scopus Profile

Orcid Profile

Educational Details:

Prof. Christopher Coe, Professor Emeritus at the University of Wisconsin-Madison, is a distinguished expert in biological psychology and psychoneuroimmunology. He earned a B.A. in Anthropology (cum laude) with a minor in Biology from City College, City University of New York, in 1971, and a Ph.D. in Biological Psychology from Downstate Medical Center, SUNY, in 1976. Following this, he completed a postdoctoral fellowship in developmental psychobiology at Stanford University Medical School (1976-77). Prof. Coe’s career has been marked by groundbreaking research on the interplay between behavior, stress, and immune function, as well as exceptional contributions to teaching and academic leadership.

Professional Experience:

Prof. Christopher Coe has had an illustrious academic career spanning over five decades, beginning as a Lecturer at the American Museum of Natural History in New York (1970-71). He held key roles at Stanford University, including Postdoctoral Fellow (1976-77), Assistant Director of the Outdoor Primate Facility (1977-79), and Assistant Professor at the School of Medicine (1981-85). Joining the University of Wisconsin-Madison in 1985, he served as Associate Professor, Director of the Harlow Center for Biological Psychology, and later as Professor (1988-2022). Honored as the W.B. Cannon Professor of Biopsychology (2001-2022), he is now Professor Emeritus and Honorary Scholar.

Research Interests:

Prof. Christopher Coe’s research spans developmental psychobiology, psychoneuroimmunology, and sociophysiology. He investigates how early life experiences shape biological and psychological development, the interplay between stress, behavior, and immune system function, and the biological basis of social interactions and their effects on health and well-being.

Research Skills:

Prof. Christopher Coe specializes in designing and conducting longitudinal studies in developmental psychobiology, with expertise in psychoneuroimmunology and animal behavioral research. He is also proficient in sociophysiological measurement techniques and advanced data analysis, enabling a comprehensive understanding of the biological and behavioral dynamics underlying health and development.

Research Projects:

Prof. Christopher Coe has spearheaded pioneering research projects on the impact of stress and early life experiences on immune development, behavioral and physiological adaptations in primates, and the psychosocial factors influencing health and resilience throughout the lifespan.

Awards and Honors:

Prof. Christopher Coe has received numerous prestigious awards, including the Chancellor’s Award for Excellence in Teaching (1997), the WARF Professorship as W.B. Cannon Professor (2001), and the Norman Cousins Award for Psychoneuroimmunology Research (2001). Other honors include the Ziskind-Somerfield Award for Innovative Research (2004), the Hilldale Award for Teaching and Scholarship (2006), the P. Barchas Award for Sociophysiology Research (2008), and an Honorary Professorship from South China Normal University (2009). He also earned the Best Research in Health and Society accolade (2011) and the UW Board of Regents Teaching Excellence Award (2013).

Conclusion:

Prof. Christopher Coe’s career exemplifies excellence in academic leadership, innovative research, and impactful teaching. His contributions to psychology and biopsychology continue to inspire scholars and shape the understanding of health, behavior, and development.

Top Notable Publications:

Biobehavioral mechanisms underlying symptoms in cancer patients with chronic graft-versus-host disease

Authors: Hansen, J.L., Rumble, M.E., Coe, C.L., Hematti, P., Costanzo, E.S.

Year: 2025

Citations: 0

Non-invasive ventral cervical magnetoneurography as a proxy of in vivo lipopolysaccharide-induced inflammation

Authors: Bu, Y., Burks, J., Yang, K., Coleman, T.P., Lerman, I.

Year: 2024

Citations: 0

Higher inflammatory proteins predict future depressive symptom severity among adolescents with lower emotional clarity

Authors: Stephenson, A.R., Ka-Yi Chat, I., Bisgay, A.T., Abramson, L.Y., Alloy, L.B.

Year: 2024

Citations: 0

Neutral sphingomyelinase regulates mechanotransduction in human engineered cardiac tissues and mouse hearts

Authors: Turner, D.G.P., De Lange, W.J., Zhu, Y., Ralphe, J.C., Glukhov, A.V.

Year: 2024

Citations: 2

Maternal Immunization with Adjuvanted Recombinant Receptor-Binding Domain Protein Provides Immune Protection against SARS-CoV-2 in Infant Monkeys

Authors: Coe, C.L., Nimityongskul, F., Lubach, G.R., Rancour, D., Schomburg, F.M.

Year: 2024

Citations: 0

Exercise does not cause post-exertional malaise in Veterans with Gulf War Illness: A randomized, controlled, dose–response, crossover study

Authors: Boruch, A.E., Barhorst, E.E., Rayne, T.J., Cook, D.B., Lindheimer, J.B.

Year: 2024

Citations: 1

Financial Hardship and Age-Related Decrements in Kidney Function among Black and White Adults in the Midlife in the United States Study

Authors: Surachman, A., Harhay, M., Santos, A.R., Almeida, D.M., Coe, C.L.

Year: 2024

Citations: 1

Lingering Effects of Early Institutional Rearing and Cytomegalovirus Infection on the Natural Killer Cell Repertoire of Adopted Adolescents

Authors: Wood, E.K., Reid, B.M., Sheerar, D.S., Gunnar, M.R., Coe, C.L.

Year: 2024

Citations: 1

Prognostic Performance of Hematological and Serum Iron and Metabolite Indices for Detection of Early Iron Deficiency Induced Metabolic Brain Dysfunction in Infant Rhesus Monkeys

Authors: Sandri, B.J., Kim, J., Lubach, G.R., Coe, C.L., Rao, R.B.

Year: 2024

Citations: 3

The Impact of Early and Recent Life Stress on Trajectories of Inflammatory Biomarkers in a Diverse Sample of Adolescents

Authors: Kautz, M.M., McArthur, B.A., Moriarity, D.P., Abramson, L.Y., Alloy, L.B.

Year: 2023

Citations: 4

Songwen Chen | Arrhythmia | Best Research Article Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Songwen Chen | Arrhythmia | Best Research Article Award

Dr. Songwen Chen, Shanghai General Hospital, China

Dr. Songwen Chen is an Associate Chief Physician at Shanghai General Hospital and a Master’s Graduate Supervisor at Shanghai Jiao Tong University School of Medicine. He specializes in cardiology and electrophysiology, with extensive experience in catheter ablation for arrhythmias such as atrial fibrillation and ventricular tachycardia. Dr. Chen holds a doctorate in Internal Medicine from Shanghai Jiao Tong University and has published widely on topics including arrhythmia management, skin sympathetic nerve activity, and catheter-based interventions. He has received numerous research grants and plays a key role in educating future cardiologists. His work continues to advance both clinical practice and research in cardiology.

Profile:

Google scholar Profile

🎓 EDUCATION 

Dr. Songwen Chen’s educational background is distinguished by his dedication to the field of medicine and cardiology. He earned his Bachelor’s degree in Medicine from Soochow University, followed by a Master’s degree in Internal Medicine from Fudan University’s Zhongshan Hospital. His pursuit of advanced knowledge continued with a Doctorate in Internal Medicine from Shanghai General Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. This strong academic foundation in medical science has provided Dr. Chen with the expertise needed to excel in clinical cardiology and electrophysiology, enabling him to make significant contributions to both research and patient care.

💼 PROFESSIONAL EXPERIENCE:

Dr. Songwen Chen is an Associate Chief Physician in the Department of Cardiology at Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, where he has worked since 2012. In addition to his clinical duties, which include performing electrophysiology studies and catheter ablation for arrhythmias, he also supervises graduate students as a Master’s Graduate Supervisor at Shanghai Jiao Tong University School of Medicine. Dr. Chen has contributed extensively to research, securing several prestigious grants, and publishing numerous studies on topics such as arrhythmia management, electrophysiology, and catheter-based interventions. His professional experience blends clinical practice with significant academic and research achievements.

🌍 Research experience  

Dr. Songwen Chen has extensive research experience in the field of cardiology, with a focus on electrophysiology and arrhythmia management. His work includes studying catheter ablation techniques for atrial fibrillation, supraventricular tachycardia, and ventricular tachycardia. Dr. Chen has made significant contributions to understanding the role of the inferior vena cava in triggering atrial fibrillation and exploring the relationship between skin sympathetic nerve activity and QT interval variability. He has published in prominent journals such as JACC: Clinical Electrophysiology and Pacing and Clinical Electrophysiology. His research is supported by prestigious grants and has led to innovative advancements in clinical cardiology.

🏅Award And Honors

Dr. Songwen Chen has received several prestigious awards and honors throughout his career, reflecting his exceptional contributions to the field of cardiology. His groundbreaking research has been recognized with grants from prominent organizations such as the National Natural Science Foundation of China and the Shanghai Municipal Commission of Health and Family Planning. Additionally, his innovative work in electrophysiology and catheter ablation for arrhythmias has earned him widespread recognition within the medical community. Dr. Chen’s academic excellence, clinical expertise, and dedication to advancing cardiology make him a highly respected figure, deserving of continued recognition and accolades in his field.

Citations:

Citations – 914
h-index1 – 71
i10-index – 27

Conclusion:

Dr. Songwen Chen stands as a distinguished figure in cardiology, merging clinical expertise with impactful research and education. His dedication to advancing electrophysiology, combined with his leadership at Shanghai General Hospital and Shanghai Jiao Tong University School of Medicine, underscores his commitment to improving cardiovascular health outcomes. Dr. Chen’s work not only elevates patient care but also inspires the next generation of medical professionals, solidifying his legacy in the field of cardiology.

TOP NOTABLE PUBLICATIONS:

Circular RNA Ttc3 regulates cardiac function after myocardial infarction by sponging miR-15b
Authors: L Cai, B Qi, X Wu, S Peng, G Zhou, Y Wei, J Xu, S Chen, S Liu
Journal: Journal of Molecular and Cellular Cardiology
Year: 2019

Triglyceride-glucose index and the risk of heart failure: evidence from two large cohorts and a mendelian randomization analysis
Authors: X Li, JSK Chan, B Guan, S Peng, X Wu, X Lu, J Zhou, JMH Hui, YHA Lee, …
Journal: Cardiovascular diabetology
Year: 2022

Activated CD4+ T cells-derived exosomal miR-142-3p boosts post-ischemic ventricular remodeling by activating myofibroblast
Authors: L Cai, G Chao, W Li, J Zhu, F Li, B Qi, Y Wei, S Chen, G Zhou, X Lu, J Xu, …
Journal: Aging (Albany NY)
Year: 2020

Micro RNA‐30c suppresses the pro‐fibrogenic effects of cardiac fibroblasts induced by TGF‐β1 and prevents atrial fibrosis by targeting TGF β RII
Authors: J Xu, H Wu, S Chen, B Qi, G Zhou, L Cai, L Zhao, Y Wei, S Liu
Journal: Journal of Cellular and Molecular Medicine
Year: 2018

Nav1.8 channels in ganglionated plexi modulate atrial fibrillation inducibility
Authors: B Qi, Y Wei, S Chen, G Zhou, H Li, J Xu, Y Ding, X Lu, L Zhao, F Zhang, …
Journal: Cardiovascular research
Year: 2014

LCZ696 ameliorates oxidative stress and pressure overload‐induced pathological cardiac remodeling by regulating the Sirt3/MnSOD pathway
Authors: S Peng, X Lu, Y Qi, J Li, J Xu, T Yuan, X Wu, Y Ding, W Li, G Zhou, Y Wei, …
Journal: Oxidative Medicine and Cellular Longevity
Year: 2020

Blocking the pulmonary vein to left atrium conduction in addition to the entrance block enhances clinical efficacy in atrial fibrillation ablation
Authors: S Chen, W Meng, D Sheng He, G Chen, F Zhang, Y Yan, Y Zhu-Ge, …
Journal: Pacing and Clinical Electrophysiology
Year: 2012

Potential role of cyanidin 3-glucoside (C3G) in diabetic cardiomyopathy in diabetic rats: an in vivo approach
Authors: W Li, S Chen, G Zhou, H Li, L Zhong, S Liu
Journal: Saudi Journal of Biological Sciences
Year: 2018

Procedural arrhythmia termination and long‐term single‐procedure clinical outcome in patients with non‐paroxysmal atrial fibrillation
Authors: G Zhou, S Chen, G Chen, F Zhang, W Meng, Y Yan, X Lu, Y Wei, S Liu
Journal: Journal of Cardiovascular Electrophysiology
Year: 2013

Age-and sex-related difference in lipid profiles of patients hospitalized with acute myocardial infarction in East China
Authors: Y Wei, B Qi, J Xu, G Zhou, S Chen, P Ouyang, S Liu
Journal: Journal of Clinical Lipidology
Year: 2014

Xingang Li | harmacology | Best Research Article Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Xingang Li | pharmacology | Best Research Article Award 

Prof. Xingang Li, Department of Pharmacy, Beijing Friendship Hospital, China

Prof. Xingang Li is the Deputy Director of the Pharmacy Department at Beijing Friendship Hospital, China, where he also serves as a Chief Pharmacist, Professor, and Ph.D. Supervisor. An expert in quantitative pharmacology and genetic pharmacology, Prof. Li has published over 50 articles in top-tier journals, with more than 1000 citations and an H-index of 20. He is an External Expert at the National Center for Drug Evaluation, a member of multiple prestigious pharmacological committees, and a reviewer for leading journals such as Biomaterials and Clin Transl Med. His research focuses on personalized medicine, drug delivery systems, and epigenetic influences on pharmacodynamics.

Profile:

Orcid Profile

🏥 Current Positions:

Prof. Li Xingang serves as the Deputy Director of the Pharmacy Department at Beijing Friendship Hospital, where he is also the Chief Pharmacist. As a Professor and Ph.D. Supervisor, he is instrumental in nurturing future generations of pharmacists and researchers. His leadership role involves overseeing advanced pharmacological practices, mentoring young scientists, and ensuring cutting-edge drug evaluation and management systems. With a strong emphasis on precision medicine, Prof. Li combines clinical expertise and research excellence to address pressing healthcare challenges.

📚 Academic Background:

Prof. Li has an extensive academic background, which underpins his outstanding contributions to quantitative pharmacology and genetic pharmacology. His role as an External Expert at the National Center for Drug Evaluation and Review Expert for the Beijing Science and Technology Plan Project showcases his authority in the field. His memberships in prestigious committees, such as the Quantitative Pharmacology Committee of the Chinese Pharmacological Society and the Epigenetics Committee, reflect his deep commitment to advancing pharmaceutical sciences.

🧪 Research Interests and Achievements:

Quantitative Pharmacology: Prof. Li has a keen interest in developing predictive models to optimize drug efficacy and safety, leveraging mathematical frameworks to personalize treatment.

Genetic Pharmacology: His research focuses on exploring genetic factors that influence drug metabolism and efficacy, aiming to enhance personalized medicine approaches.

Prof. Li has successfully led over ten major projects, including initiatives funded by the Ministry of Science and Technology, the National Natural Science Foundation, and the Beijing Science and Technology Plan. These projects address critical areas like drug delivery systems, personalized pharmacotherapy, and genetic determinants of drug response.

🖋️ Publication Achievements:

Prof. Li’s academic rigor is evident in his extensive publication record, with over 50 articles in Q1 journals such as Nano Letters, Acta Pharmacologica Sinica, and Phytomedicine. His works have been cited more than 1000 times, and he holds an impressive H-index of 20, reflecting his impact on the scientific community. His publications explore innovative drug delivery systems, genetic biomarkers, and clinical pharmacokinetics, contributing significantly to global pharmacological advancements.

🏆 Scholarships and Awards:

Prof. Li has received numerous accolades for his contributions:

  • Servier Young Hospital Pharmacy Award, China Pharmaceutical Society
  • Outstanding Pharmacist Award, Beijing Pharmaceutical Society
  • Recognized for Outstanding Papers and groundbreaking research, reflecting his excellence in clinical pharmacy and translational research.

🧑‍🔬 Professional Associations and Editorial Roles:

Prof. Li is actively involved in professional organizations, including the Chinese Pharmacological Society and the China Pharmaceutical Education Association. He serves as an Editorial Board Member for journals such as China Hospital Pharmacy Evaluation and Analysis and Chinese Pharmacy, ensuring the dissemination of high-quality research.

As a Reviewer for prestigious journals like Biomaterials and Clin Transl Med, he evaluates cutting-edge studies in pharmacology, bioinformatics, and materials science, further contributing to his field’s knowledge base.

💻 Bioinformatics and Laboratory Experience:

Prof. Li integrates bioinformatics tools into his research to analyze complex datasets and identify genetic markers associated with drug response. His laboratory is equipped with advanced technologies for pharmacokinetic modeling, epigenetic profiling, and drug formulation analysis, enabling groundbreaking discoveries.

🎓 Training, Workshops, and Oral Presentations:

Prof. Li regularly participates in international conferences, presenting his research findings and engaging with global experts. His oral presentations at prestigious forums highlight advancements in therapeutic drug monitoring (TDM), anesthesiology pharmacy, and intravenous preparation management, solidifying his reputation as a thought leader.

✅ Tasks Completed as a Researcher:

Prof. Li has successfully completed tasks ranging from designing clinical trials to publishing high-impact research. His ability to translate laboratory findings into practical solutions for patient care exemplifies his commitment to improving healthcare outcomes.

🌟 Success Factors and Key Contributions:

Prof. Li’s success stems from his:

  • Collaborative approach in multidisciplinary projects
  • Innovative methodologies in drug evaluation and genetic research
  • Dedication to mentoring young professionals and fostering academic growth

🔬 Ongoing Research Projects:

His current projects delve into:

  • Advanced drug delivery systems to enhance treatment efficacy
  • Epigenetic influences on pharmacodynamics
  • Personalized medicine approaches using genetic profiling

🔍 Conclusion:

Prof. Li Xingang is a distinguished leader in the field of pharmacology, whose contributions span clinical excellence, innovative research, and impactful publications. His work in quantitative and genetic pharmacology, combined with his dedication to mentoring and professional engagement, sets him apart as a visionary in healthcare. His achievements and ongoing endeavors continue to shape the future of precision medicine and pharmacological sciences.

Top Notable Publications:

1. Immune-Related Colitis Induced by Camrelizumab: A Case Report

Authors: Xingang Li

Journal: Journal of Inflammation Research

Year: 2023

2. Population pharmacokinetics and dosing optimisation of imipenem in critically ill patients

Authors: Xingang Li

Journal: European Journal of Hospital Pharmacy: Science and Practice-

Year: 2023

3. Association of Alcohol Drinking and Helicobacter pylori Infection: A Meta-analysis

Authors: Xingang Li

Journal: Journal of Clinical Gastroenterology

Year: 2023

4. Population pharmacokinetics of oxcarbazepine 10-monohydroxy derivative in Chinese adult epileptic patients

Authors: Xingang Li

Journal: European Journal of Hospital Pharmacy: Science and Practice

Year: 2022

5. Association between GNAQ Gene DNA Methylation and Vascular Recurrence in Patients with Acute Ischemic Stroke or Transient Ischemic Attack

Authors: Xingang Li

Journal: Cerebrovascular Diseases (Basel, Switzerland)

Year: 2022

6. Impact of Azithromycin on Forsythiaside Pharmacokinetics in Rats: A Population Modeling Method

Authors: Xingang Li

Journal: Current Medical Science

Year: 2022

7. Docetaxel population pharmacokinetic modelling and simulation in Chinese cancer patients

Authors: Xingang Li

Journal: Annals of Translational Medicine

Year: 2022

8. Development of a multivariable clinical prediction model for liposomal doxorubicin-induced cardiotoxicity in adult breast cancer patients: A retrospective multicenter study

Authors: Xingang Li

Journal: Annals of Translational Medicine

Year: 2022

9. Population pharmacokinetics of methotrexate in pediatric patients with acute lymphoblastic leukemia and malignant lymphoma

Authors: Xingang Li

Journal: Xenobiotica

Year: 2022

10. The clinical population pharmacokinetics, metabolomics, and therapeutic analysis of alkaloids from Alstonia scholaris leaves in acute bronchitis patients

Authors: Xingang Li

Journal: Phytomedicine

Year: 2022

Fulin Liu | Cardiology | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Fulin Liu | Cardiology | Best Researcher Award

Prof. Fulin Liu, Affiliated Hospital of Hebei University , China

Prof. Fulin Liu is a distinguished researcher and cardiac surgeon affiliated with the Affiliated Hospital of Hebei University, where he has worked since 1988. He holds a degree from Hebei Medical University and has made significant contributions to cardiovascular health, particularly in myocardial ischemia-reperfusion injury and the therapeutic effects of hydrogen-rich water. Liu has authored numerous high-impact journal articles, with recent work focusing on mitochondrial function, glioma research, and innovative healthcare solutions. His research is widely recognized in leading medical journals, underscoring his global impact and ongoing commitment to advancing medical science and patient care.

Author Profile:

🎓 Education:

Prof. Fulin Liu completed his undergraduate education at Hebei Medical University in Shijiazhuang City, Hebei, China. He attended the university from September 1983 to June 1988, where he received a medical degree, which laid the foundation for his career in cardiac surgery and medical research. This academic background has been pivotal in shaping his research focus, particularly in the fields of cardiovascular health, ischemia-reperfusion injury, and the application of hydrogen-rich water in medical treatments. Liu’s educational experiences at Hebei Medical University have significantly influenced his innovative contributions to healthcare and medical science.

💼 Professional Experience:

Prof. Fulin Liu has extensive professional experience in both clinical and research settings. Since 1988, he has been a cardiac surgeon at the Affiliated Hospital of Hebei University, where he has developed expertise in treating cardiovascular conditions, particularly myocardial ischemia-reperfusion injury. In addition to his clinical role, Liu has made significant contributions to medical research, publishing numerous articles on topics such as hydrogen-rich water, mitochondrial function, and glioma. His work bridges the gap between clinical practice and scientific discovery, advancing both patient care and medical knowledge. Liu’s career reflects a dedicated commitment to improving cardiovascular health and innovative therapies.

🌍Research Contributions:

Prof. Fulin Liu’s research contributions focus primarily on cardiovascular health, particularly myocardial ischemia-reperfusion injury and the protective effects of hydrogen-rich water. His studies have revealed critical insights into mitochondrial function and its role in heart disease, with a focus on improving therapeutic strategies. Liu has also made notable contributions to the understanding of gliomas, including the role of circular RNAs and N6-methyladenosine modifications in tumor progression. His work extends to advanced healthcare technologies, such as knowledge graphs and mobile computing in medical applications. Through his numerous published articles, Liu continues to drive innovative research with significant clinical and therapeutic implications.

🥇Award and Honors:

Prof. Fulin Liu has received numerous awards and honors throughout his distinguished career, recognizing his contributions to the field of cardiac surgery and medical research. His groundbreaking work on myocardial ischemia-reperfusion injury, hydrogen-rich water’s therapeutic effects, and his studies on gliomas have earned him widespread acclaim in the scientific community. Liu’s research has been published in top-tier medical journals, and his expertise has garnered international recognition. His dedication to advancing both clinical practices and scientific understanding has established him as a leader in his field, earning him significant accolades and reinforcing his reputation as a pioneering researcher.

Conclusion:

Prof. Fulin Liu’s extensive research and clinical expertise have made him a prominent figure in the field of cardiac surgery and biomedical research. His work on myocardial ischemia-reperfusion injury, hydrogen-rich water, and its therapeutic potential highlights his commitment to advancing cardiovascular medicine. Liu’s contributions to the understanding of molecular mechanisms in diseases like glioma further underscore his multidisciplinary approach to health research. With a remarkable publication record and ongoing involvement in clinical practice, Liu’s impact on both academic and medical communities is profound, establishing him as a leading figure in his field.

📚Publication Top Notes:

Hydrogen Protects Mitochondrial Function by Increasing the Expression of PGC-1α and Ameliorating Myocardial Ischaemia–Reperfusion Injury
Journal of Cellular and Molecular Medicine, 2024
📖 Citations: 0
[DOI: 10.1111/jcmm.70236]

Spatiotemporal lipidomics reveals key features of brain lipid dynamic changes after cerebral ischemia and reperfusion therapy
Pharmacological Research, 2022
🧠 Citations: 15
[DOI: 10.1016/j.phrs.2022.106482]

Identification and characterization of N6-methyladenosine modification of circRNAs in glioblastoma
Journal of Cellular and Molecular Medicine, 2021
🔬 Citations: 8
[DOI: 10.1111/jcmm.16750]

Multitask Healthcare Management Recommendation System Leveraging Knowledge Graph
Journal of Healthcare Engineering, 2021
💡 Citations: 19
[DOI: 10.1155/2021/1233483]

Medical Knowledge Graph in Chinese Using Deep Semantic Mobile Computation Based on IoT and WoT
Wireless Communications and Mobile Computing, 2021
🌐 Citations: 6
[DOI: 10.1155/2021/5590754]

M6A modification in RNA: Biogenesis, functions and roles in gliomas
Journal of Experimental and Clinical Cancer Research, 2020
🧬 Citations: 117
[DOI: 10.1186/s13046-020-01706-8]

Metabolomics Analysis of the Effect of Hydrogen-Rich Water on Myocardial Ischemia-Reperfusion Injury in Rats
Journal of Bioenergetics and Biomembranes, 2020
💧 Citations: 6
[DOI: 10.1007/s10863-020-09835-7]

Advances in circular RNAs and their role in glioma (Review)
International Journal of Oncology, 2020
🔄 Citations: 26
[DOI: 10.3892/ijo.2020.5049]

New understanding of the damage of SARS-CoV-2 infection outside the respiratory system
Biomedicine and Pharmacotherapy, 2020
🦠 Citations: 222
[DOI: 10.1016/j.biopha.2020.110195]

Pressurizing and Stretching Experiment in Arterialized Veins of Rabbits
Yiyong Shengwu Lixue/Journal of Medical Biomechanics, 2020
🐇 Citations: Not available
[DOI: 10.3969/j.issn.1005-8936.2020.02.006]

Cancan Zhou | Hepatic toxicology | Best Research Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Cancan Zhou | Hepatic toxicology  | Best Research Award

Prof. Cancan Zhou, Shanghai Tenth People’s Hospital, China

Prof. Cancan Zhou is a distinguished researcher at the Department of Pharmacy, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, China. He is an active member of the Shanghai Pharmacological Society Clinical Drug Evaluation Committee and the Shanghai Hospital Association Clinical Pharmaceutical Management Committee. Prof. Zhou has led a youth project under the National Natural Science Foundation of China, funded by the Shanghai Sailing Program, and has authored over 10 SCI-indexed papers as the first or corresponding author. Her expertise focuses on hepatic toxicology, drug safety, and advanced pharmacological research.

Profile:

Scopus Profile

📘 EARLY ACADEMIC PURSUITS:

The Department of Pharmacy at Shanghai Tenth People’s Hospital, affiliated with Tongji University School of Medicine, Shanghai, China, serves as a cornerstone for advanced clinical pharmaceutical education and research. With a strong emphasis on evidence-based practices and innovation, the academic foundation was laid through rigorous training in drug evaluation, pharmaceutical management, and patient-centric care. This foundation has enabled significant advancements in the field of clinical pharmacy.

💼 PROFESSIONAL ENDEAVORS:

As a Member of the Shanghai Pharmacological Society Clinical Drug Evaluation Committee and the Shanghai Hospital Association Clinical Pharmaceutical Management Committee, the individual plays a pivotal role in shaping clinical pharmaceutical policies and practices. These roles underscore a dedication to improving healthcare systems, advancing drug evaluation protocols, and ensuring the highest standards of pharmaceutical care.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON Hepatic toxicology :

A highlight of this career is the successful leadership of a youth project under the National Natural Science Foundation of China, supported by the prestigious Shanghai Sailing Program. The research primarily focuses on:

  • Clinical Drug Evaluation 🩺
  • Innovative Pharmaceutical Management Strategies 📈
  • Advancing Patient-Centered Therapies 🤝

This work has had a transformative effect on improving drug safety, efficacy, and accessibility in clinical settings.

🌟 IMPACT AND INFLUENCE:

With more than 10 SCI-indexed publications as the first or corresponding author, the individual’s research contributions have significantly influenced both academic discussions and practical applications in the pharmaceutical sciences. These publications have enhanced the understanding of clinical drug evaluation processes and established benchmarks for excellence in research methodologies.

📖 ACADEMIC CITES:

The widespread citation of these publications reflects their impact on the global scientific community. The work has inspired new research, informed clinical guidelines, and contributed to the development of innovative therapeutic strategies. These achievements highlight the individual’s reputation as a thought leader in pharmaceutical sciences.

🔮 LEGACY AND FUTURE CONTRIBUTIONS:

This career reflects a legacy of excellence, blending cutting-edge research with impactful professional service. Moving forward, the focus is expected to center on:

  • Integrating Artificial Intelligence into Drug Evaluation 🤖
  • Developing Sustainable Healthcare Practices 🌱
  • Expanding International Collaborations in Clinical Research 🌍

These contributions aim to enhance healthcare outcomes, streamline pharmaceutical processes, and pave the way for next-generation drug development and management.

💡 OTHER IMPORTANT TOPICS:

🏆 LEADERSHIP IN CLINICAL PHARMACEUTICAL COMMITTEES

Active participation in key committees showcases exemplary leadership and the ability to influence policy decisions that shape the future of clinical pharmacy in Shanghai and beyond.

📈 SUCCESS IN YOUTH PROJECTS

The youth project, supported by competitive funding, highlights the individual’s capacity to lead high-impact research. This success demonstrates both academic merit and the ability to deliver results in fast-evolving scientific domains.

👨‍🏫 MENTORSHIP AND EDUCATION

As part of Tongji University School of Medicine, the individual likely contributes to training the next generation of clinical pharmacists, fostering innovation, and promoting ethical and evidence-based practices.

🌍 VISION FOR GLOBAL PHARMACEUTICAL INTEGRATION

Future aspirations include strengthening cross-border collaborations to harmonize pharmaceutical standards, improve global drug accessibility, and contribute to sustainable healthcare practices worldwide.

✨ CONCLUSION:

The professional journey outlined reflects a remarkable blend of academic excellence, impactful research, and leadership in clinical pharmacy. With a clear vision for future contributions, this profile is set to continue driving innovation, improving patient care, and leaving a lasting legacy in pharmaceutical sciences.

TOP NOTABLE PUBLICATIONS:

STING Signaling Contributes to Methotrexate-Induced Liver Injury by Regulating Ferroptosis in Mice

Authors: Wang, H.-F.; He, Y.-Q.; Ke, Z.; Zhou, C.-C.; Xu, J.-S.

Journal: Ecotoxicology and Environmental Safety

Year: 2024

Natural Products for the Treatment of Chemotherapy-Related Cognitive Impairment and Prospects of Nose-to-Brain Drug Delivery

Authors: He, Y.-Q.; Zhou, C.-C.; Jiang, S.-G.; Tao, X.; Chen, W.-S.

Journal: Frontiers in Pharmacology

Year: 2024

Ursodeoxycholic Acid Alleviates Sepsis-Induced Lung Injury by Blocking PANoptosis via STING Pathway

Authors: He, Y.-Q.; Deng, J.-L.; Zhou, C.-C.; Tao, X.; Chen, W.-S.

Journal: International Immunopharmacology

Year: 2023

Long Survival in a Pancreatic Carcinoma Patient with Multi-Organ Toxicities After Sintilimab Treatment: A Case Report

Authors: Ni, C.-X.; Zhao, Y.; Qian, H.; Li, D.-J.; Xu, Q.

Journal: Frontiers in Pharmacology

Year: 2023

Clinical Features of Omicron SARS-CoV-2 Variants Infection Associated with Co-Infection and ICU-Acquired Infection in ICU Patients

Authors: Li, D.-J.; Zhou, C.-C.; Huang, F.; Shen, F.-M.; Li, Y.-C.

Journal: Frontiers in Public Health

Year: 2023

Zinc Supplementation Ameliorates Sorafenib-Induced Cognitive Impairment Through ROS/JNK Signaling Pathway

Authors: Zhou, C.-C.; He, Y.-Q.; Qiu, Y.-S.; Shen, F.-M.; Li, D.-J.

Journal: Biological Trace Element Research

Year: 2023

Exerkine Fibronectin Type-III Domain-Containing Protein 5/Irisin-Enriched Extracellular Vesicles Delay Vascular Ageing by Increasing SIRT6 Stability

Authors: Chi, C.; Fu, H.; Li, Y.-H.; Li, D.-J.; Wang, P.

Journal: European Heart Journal

Year: 2022

Activating α7nAChR Ameliorates Abdominal Aortic Aneurysm Through Inhibiting Pyroptosis Mediated by NLRP3 Inflammasome

Authors: Fu, H.; Shen, Q.-R.; Zhao, Y.; Liang, G.; Shen, F.-M.

Journal: Acta Pharmacologica Sinica

Year: 2022

Lead Exposure in Developmental Ages Promotes Aβ Accumulation by Disturbing Aβ Transportation in Blood-Cerebrospinal Fluid Barrier/Blood–Brain Barriers and Impairing Aβ Clearance in the Liver

Authors: Zhou, C.-C.; Wang, X.-J.; Li, Z.-C.; Shen, F.-M.; Li, D.-J.

Journal: Biological Trace Element Research

Year: 2022

Abdominal Aortic Aneurysm: Pathological Mechanism and Animal Model

Authors: Fu, H.; Zhou, C.; Li, D.; Shen, F.

Journal: Acta Academiae Medicinae Sinicae

Year: 2022

Yumei Li | Pediatric Cardiology | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof.Yumei Li | Pediatric Cardiology | Best Researcher Award

Prof. Yumei Li,  The First Hospital of Jilin University,  China.

Yumei Li is the Executive Director of the Children’s Medical Center and Director of the Pediatric Intensive Care Unit at the First Hospital of Jilin University. A renowned leader in Pediatric Critical Care Medicine, she founded the largest and most advanced pediatric critical care unit in Jilin Province. With over 31 years of experience, Professor Li has led 50 research projects and published 130 papers, including 45 SCI-indexed articles. She has mentored doctoral students, contributed to eight key textbooks, and secured nearly 4 million yuan in research funding. Her work in pediatric liver transplantation and life support technology has driven innovation and saved countless lives.

Author Profile:

Scopus Profile

Summary of Suitability for Best Researcher Award

Dr. Yumei Li, Executive Director of the Children’s Medical Center and Director of the Pediatric Intensive Care Unit at the First Hospital of Jilin University, is an exemplary candidate for the Best Researcher Award. With over 31 years of experience, Dr. Li has made pioneering contributions in pediatric critical care, particularly in pediatric liver transplantation and extracorporeal life support technologies, transforming clinical care standards in Jilin Province.Her impressive research portfolio includes leading 50 national and provincial projects, securing nearly 4 million yuan in research funding. Dr. Li has published 130 research papers, with 45 indexed in SCI journals, reflecting her significant global impact. Additionally, her academic influence is demonstrated through 16 teaching grants, authorship of 8 major textbooks, and supervision of 21 research scholars (15 graduated, 6 ongoing).

🎓 Education:

Yumei Li holds a doctoral degree in Pediatrics, showcasing her strong academic foundation and commitment to advancing medical knowledge. As a professor and doctoral supervisor, she has dedicated nearly 30 years to pediatric education and research. Her expertise spans pediatric critical care, with significant contributions to clinical advancements and medical education. She has played a key role in developing pediatric textbooks and teaching materials, serving as an editorial board member for several publications. Her passion for education and mentorship has shaped future pediatric specialists, solidifying her reputation as a distinguished educator and leader in the field of Pediatrics.

💼 Professional Experience:

Yumei Li has over 31 years of professional experience in Pediatrics and Pediatric Critical Care Medicine. She currently serves as the Executive Director of the Children’s Medical Center and Director of the Pediatric Intensive Care Unit at the First Hospital of Jilin University. As the founder of Pediatric Critical Care Medicine in Jilin Province, she has played a pivotal role in developing the region’s most advanced pediatric critical care unit. Her expertise spans pediatric liver transplantation and extracorporeal life support technology. Additionally, she is a professor, doctoral supervisor, and an influential contributor to medical education and clinical innovation

🌍Research Contributions:

Yumei Li has over 31 years of professional experience in Pediatrics and Pediatric Critical Care Medicine. She currently serves as the Executive Director of the Children’s Medical Center and Director of the Pediatric Intensive Care Unit at the First Hospital of Jilin University. As the founder of Pediatric Critical Care Medicine in Jilin Province, she has played a pivotal role in developing the region’s most advanced pediatric critical care unit. Her expertise spans pediatric liver transplantation and extracorporeal life support technology. Additionally, she is a professor, doctoral supervisor, and an influential contributor to medical education and clinical innovation.

🥇Award and Honors:

Yumei Li has received 16 awards and honors recognizing her outstanding contributions to pediatric critical care and medical research. As the founder of the Pediatric Critical Care Medicine Department in Jilin Province, she has been honored for advancing pediatric liver transplantation and extracorporeal life support technology. Her leadership and dedication have earned her numerous accolades for excellence in clinical practice, teaching, and research. Professor Li’s impactful contributions include leading 50 research projects and publishing 130 papers, which have significantly influenced pediatric healthcare. These achievements highlight her commitment to innovation, education, and improving patient outcomes, solidifying her reputation as a distinguished medical professional.

Conclusion:

Professor Yumei Li has made outstanding contributions to the field of Pediatric Critical Care Medicine through her exceptional leadership, research, and clinical expertise. With over 31 years of experience, she has established the largest pediatric critical care unit in Jilin Province, significantly advancing pediatric liver transplantation and extracorporeal life support technologies. Her impressive research portfolio, including 50 funded projects and 130 publications with 45 SCI-indexed papers, reflects her commitment to innovation and academic excellence. Professor Li’s dedication to education, mentorship, and technological advancements highlights her as a pioneering figure, making her a deserving candidate for the Best Researcher Award.

📚Publication Top Notes:

📄 “Comprehensive review of indicators and techniques for optical mapping of intracellular calcium ions” – Cerebral Cortex, 2024, 34(8), bhae346 | Cited: 0

🧒 “Children with severe neurological symptoms associated with SARS-CoV-2 infection during Omicron pandemic in China” – Pediatric Research, 2024, 95(4), pp. 1088–1094 | Cited: 0

🏥 “Association between BNP and all-cause mortality in critically ill children: a cohort study” – Pediatric Research, 2024 | Cited: 0

🦠 “Biliary atresia: the role of gut microbiome, and microbial metabolites” – Frontiers in Cellular and Infection Microbiology, 2024, 14, 1411843 | Cited: 0

🍊 “Nobiletin from citrus peel: a promising therapeutic agent for liver disease-pharmacological characteristics, mechanisms, and potential applications” – Frontiers in Pharmacology, 2024, 15, 1354809 | Cited: 4

🚨 “Demographics and Clinical Characteristics Assessment of Severe Acute Toxic Ingestions in Pediatric Patients: A Single-Center Study in Jilin Province of China” – Pediatric Emergency Care, 2023, 39(12), pp. 957–962 | Cited: 0

🧪 “Nanomaterials-based precision sonodynamic therapy enhancing immune checkpoint blockade: A promising strategy targeting solid tumor” – Materials Today Bio, 2023, 23, 100796 | Cited: 6

🧠 “Contactin-associated protein-like 2 antibody-associated autoimmune encephalitis in children: case reports and systematic review of literature” – Acta Neurologica Belgica, 2023, 123(5), pp. 1663–1678 | Cited: 0

⚛️ “One-Component Artificial Gustatory System Based on Hydrogen-Bond Organic Framework for Discrimination of Versatile Analytes” – Advanced Functional Materials, 2023, 33(24), 2300091 | Cited: 22

🔄 “Therapeutic plasma exchange in anti-N-methyl-D-aspartate receptor encephalitis” – Therapeutic Apheresis and Dialysis, 2023, 27(2), pp. 197–206 | Cited: 0